231 related articles for article (PubMed ID: 19733804)
21. The Gail model predicts breast cancer in women with suspicious radiographic lesions.
Weik JL; Lum SS; Esquivel PA; Tully RJ; Bae WC; Petersen FF; Jaque JM; Reeves ME; Garberoglio CA
Am J Surg; 2005 Oct; 190(4):526-9. PubMed ID: 16164914
[TBL] [Abstract][Full Text] [Related]
22. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
[TBL] [Abstract][Full Text] [Related]
23. Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?
Langer SA; Horst KC; Ikeda DM; Daniel BL; Kong CS; Dirbas FM
Am J Surg; 2005 Oct; 190(4):633-40. PubMed ID: 16164938
[TBL] [Abstract][Full Text] [Related]
24. [MRI-guided biopsy of suspicious abnormalities in the breast].
Meeuwis C; van den Bosch MA; Houwert KA; Fernandez-Gallardo AM; van Hillegersberg R; Mali WP
Ned Tijdschr Geneeskd; 2006 Aug; 150(32):1780-7. PubMed ID: 16948241
[TBL] [Abstract][Full Text] [Related]
25. The negative predictive value of breast Magnetic Resonance Imaging in noncalcified BIRADS 3 lesions.
Dorrius MD; Pijnappel RM; Sijens PE; van der Weide MC; Oudkerk M
Eur J Radiol; 2012 Feb; 81(2):209-13. PubMed ID: 21251784
[TBL] [Abstract][Full Text] [Related]
26. A review of current evidence-based clinical applications for breast magnetic resonance imaging.
DeMartini W; Lehman C
Top Magn Reson Imaging; 2008 Jun; 19(3):143-50. PubMed ID: 18941394
[TBL] [Abstract][Full Text] [Related]
27. Malignant lesions initially categorized as probably benign breast lesions: retrospective review of ultrasonographic, clinical and pathologic characteristics.
Moon HJ; Kim MJ; Kwak JY; Yoon JH; Kim SJ; Sohn YM; Kim EK
Ultrasound Med Biol; 2010 Apr; 36(4):551-9. PubMed ID: 20350681
[TBL] [Abstract][Full Text] [Related]
28. Detection and localization of occult lesions using breast magnetic resonance imaging: initial experience in a community hospital.
Friedman P; Sanders L; Russo J; Sharo R; Swaminathan S; Smith R
Acad Radiol; 2005 Jun; 12(6):728-38. PubMed ID: 15935971
[TBL] [Abstract][Full Text] [Related]
29. Categorization of non-mass-like breast lesions detected by MRI.
Sakamoto N; Tozaki M; Higa K; Tsunoda Y; Ogawa T; Abe S; Ozaki S; Sakamoto M; Tsuruhara T; Kawano N; Suzuki T; Yamashiro N; Fukuma E
Breast Cancer; 2008; 15(3):241-6. PubMed ID: 18224381
[TBL] [Abstract][Full Text] [Related]
30. Cancelation of MRI guided breast biopsies for suspicious breast lesions identified at 3.0 T MRI: reasons, rates, and outcomes.
Johnson KS; Baker JA; Lee SS; Soo MS
Acad Radiol; 2013 May; 20(5):569-75. PubMed ID: 23473719
[TBL] [Abstract][Full Text] [Related]
31. Utility of breast MRI for evaluation of residual disease following excisional biopsy.
Wilkinson J; Appleton CM; Margenthaler JA
J Surg Res; 2011 Oct; 170(2):233-9. PubMed ID: 21550064
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim H; Lee J; Cheung JY
AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
[TBL] [Abstract][Full Text] [Related]
33. Role of MRI in screening women at high risk for breast cancer.
Lehman CD
J Magn Reson Imaging; 2006 Nov; 24(5):964-70. PubMed ID: 17036340
[TBL] [Abstract][Full Text] [Related]
34. Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast.
Beran L; Liang W; Nims T; Paquelet J; Sickle-Santanello B
Am J Surg; 2005 Oct; 190(4):592-4. PubMed ID: 16164928
[TBL] [Abstract][Full Text] [Related]
35. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results.
Pinker K; Grabner G; Bogner W; Gruber S; Szomolanyi P; Trattnig S; Heinz-Peer G; Weber M; Fitzal F; Pluschnig U; Rudas M; Helbich T
Invest Radiol; 2009 Sep; 44(9):553-8. PubMed ID: 19652611
[TBL] [Abstract][Full Text] [Related]
36. Breast magnetic resonance imaging: initial experience in Kuwait.
Al-Khawari H; Kovacs A; Athyal R; Al-Manfouhi H; Fayaz MS; Madda JP
Med Princ Pract; 2009; 18(2):143-8. PubMed ID: 19204434
[TBL] [Abstract][Full Text] [Related]
37. [Value of magnetic resonance imaging in diagnosing breast lesions which need biopsy].
Ling H; Gu YJ; Wang XH; Liu GY; Huang O; Wang LP; Shen KW; Shen ZZ
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1036-9. PubMed ID: 17074240
[TBL] [Abstract][Full Text] [Related]
38. Study of breast lump of 2246 cases by fine needle aspiration.
Pradhan M; Dhakal HP
JNMA J Nepal Med Assoc; 2008; 47(172):205-9. PubMed ID: 19079396
[TBL] [Abstract][Full Text] [Related]
39. Impact of clinical and lesion characteristics on the results of MR-guided wire localizations of the breast using an open 1.0-T MRI system.
Krug KB; Ulhaas A; Hellmich M; Schwabe H; Krämer S; Malter W; Müller D; Markiefka B; Maintz D
Invest Radiol; 2013 Jun; 48(6):445-51. PubMed ID: 23538885
[TBL] [Abstract][Full Text] [Related]
40. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?
Grobmyer SR; Mortellaro VE; Marshall J; Higgs GM; Hochwald SN; Mendenhall NP; Copeland EM; Cance WG
J Am Coll Surg; 2008 May; 206(5):1045-50; discussion 1050-2. PubMed ID: 18471753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
